by Nakita | Feb 28, 2026 | Latest News
NICE publishes Quality Standard for rare disease NICE has published a Quality Standard for Rare Disease which sets out what high-quality sustainable care, treatment, and management should look like for rare diseases. We hope that this will help improve services, care,...
by Nakita | Feb 7, 2026 | Research Opportunities
The General Pharmaceutical Council (GPhC) The General Pharmaceutical Council (GPhC) makes sure pharmacy is safe and effective for patients and the public. They are inviting patients, carers, and members of the public to share their views on pharmacy services across...
by Nakita | Feb 7, 2026 | Research Opportunities
IMID BioResource Be part of the Immune Mediated Inflammatory Diseases (IMID) BioResource! It’s a research tissue bank of 18,000 individuals with immune-mediated diseases participating in health research. Currently, however, the patient population is not accurately...
by Nakita | Jan 22, 2026 | Latest News
NICE approves obinutuzumab to treat lupus nephritis in England and Wales NICE have recommended that a new treatment, obinutuzumab, can be used in combination with mycophenolate mofetil (MMF) to treat some patients with lupus nephritis in the NHS in England and Wales. ...
by Nakita | Jan 20, 2026 | Blog
Article by Amber S. Today, Monday 20th January 2026, is the International Day of Acceptance – a day dedicated to embracing life as it is, with all its challenges and changes. For those of us living with a chronic illness, acceptance isn’t just a word. It’s a daily...
